Dr.Surbhi Kansal, and Mainsha Jain. “IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC ESBL PRODUCING ENTEROBACTERIACEAE”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 33, no. 2, May 2026, pp. 841-52, https://doi.org/10.69980/1gsrfr34.